| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.18 | 0.02 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.02 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.17 | 0.02 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.17 | 0.02 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.02 |